Supervised Exercise and Revascularization for Intermittent Claudication

The combination of optimal medical treatment plus angioplasty plus supervised exercise seems to be the first line of treatment for patients with intermittent claudication, in terms of maximum walking distance and best quality of life. This combination requires a multidisciplinary team for the best possible results.

Continuar con la actividad física luego de un IAM reduce la mortalidad

The aim of this study was to conduct a meta-analysis comparing all therapeutic strategies for intermittent claudication, including optimal medical treatment, peripheral angioplasty, supervised exercise therapy, and their corresponding combinations, in order to determine the best treatment for intermittent claudication.

Intermittent claudication is a common problem that limits physical activity, decreases quality of life, and is associated with more cardiovascular events. There are previous meta-analyses, but none tested the impact of strategy combinations.

This study included data from 37 randomized studies, reaching almost 3000 patients with intermittent claudication (mean age was 68 years; 54.5% of patients were men). Comparisons were established between best medical treatment vs. supervised exercise vs. angioplasty vs. angioplasty plus supervised exercise.


Read also: Many Guidelines, Much Confusion. Blood Pressure Targets in the Elderly.


Angioplasty plus supervised exercise outperformed all other possible treatment strategies and obtained the maximum walking distance gain, 290 meters (p < 0.001).

As regards quality of life, the combination of angioplasty and supervised exercise also outperformed all other strategies. This does not mean that optimal medical treatment should be overlooked, since it acts over the whole range of cardiovascular disease.

The best course of action is a combination of all three strategies: optimal medical treatment aimed at a long/medium-term reduction in events (all cardiovascular events), angioplasty so that the patient experiences an acute difference and is able to begin with a supervised exercise plan, and, finally, such plan for result optimization and maintenance over time.

Original Title: Supervised Exercise Therapy and Revascularization for Intermittent Claudication Network Meta-Analysis of Randomized Controlled Trials.

Reference: Athanasios Saratzis et al. J Am Coll Cardiol Intv 2019, Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

A New Asymptomatic Carotid Stenosis Paradigm? CREST-2 Trial Unified Results

Severe asymptomatic carotid stenosis continues to be controversial seeing the optimization of intensive medical therapy (IMT) and the availability lower periprocedural risk revascularization techniques....

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

Hypertriglyceridemia as Key Factor to Abdominal Aortic Aneurysm Development and Rupture: Genetic and Experimental Evidence

Abdominal aortic aneurysm (AAA) is a deadly vascular disease with no effective drug treatment, and risk of rupture reaching up to 80%. Even though...

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population carries a high burden of comorbidities and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...